Bridgeway Capital Management’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,193
| Closed | -$164K | – | 1282 |
|
|
2024
Q3 | $164K | Hold |
10,193
| – | – | ﹤0.01% | 1102 |
|
|
2024
Q2 | $275K | Hold |
10,193
| – | – | 0.01% | 982 |
|
|
2024
Q1 | $199K | Sell |
10,193
-5,000
| -33% | -$97.5K | ﹤0.01% | 1111 |
|
|
2023
Q4 | $314K | Hold |
15,193
| – | – | 0.01% | 1057 |
|
|
2023
Q3 | $483K | Hold |
15,193
| – | – | 0.01% | 877 |
|
|
2023
Q2 | $510K | Buy |
15,193
+693
| +5% | +$23.3K | 0.01% | 891 |
|
|
2023
Q1 | $605K | Buy |
+14,500
| New | +$605K | 0.02% | 839 |
|
|
2022
Q4 | – | Sell |
-640
| Closed | -$31K | – | 1448 |
|
|
2022
Q3 | $31K | Buy |
+640
| New | +$31K | ﹤0.01% | 1372 |
|
|
2020
Q2 | – | Sell |
-6,603
| Closed | -$477K | – | 1385 |
|
|
2020
Q1 | $477K | Sell |
6,603
-1,167
| -15% | -$84.3K | 0.01% | 780 |
|
|
2019
Q4 | $555K | Buy |
7,770
+5,500
| +242% | +$393K | 0.01% | 935 |
|
|
2019
Q3 | $119K | Hold |
2,270
| – | – | ﹤0.01% | 1233 |
|
|
2019
Q2 | $122K | Buy |
+2,270
| New | +$122K | ﹤0.01% | 1232 |
|
|
2018
Q4 | – | Sell |
-1,667
| Closed | -$778K | – | 1438 |
|
|
2018
Q3 | $778K | Sell |
1,667
-833
| -33% | -$389K | 0.01% | 1001 |
|
|
2018
Q2 | $994K | Hold |
2,500
| – | – | 0.01% | 878 |
|
|
2018
Q1 | $764K | Buy |
2,500
+1,667
| +200% | +$509K | 0.01% | 936 |
|
|
2017
Q4 | $245K | Hold |
833
| – | – | ﹤0.01% | 1247 |
|
|
2017
Q3 | $456K | Hold |
833
| – | – | 0.01% | 1118 |
|
|
2017
Q2 | $497K | Buy |
+833
| New | +$497K | 0.01% | 1093 |
|